These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prevention of nitric oxide-mediated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease in mice by tea phenolic epigallocatechin 3-gallate. Choi JY; Park CS; Kim DJ; Cho MH; Jin BK; Pie JE; Chung WG Neurotoxicology; 2002 Sep; 23(3):367-74. PubMed ID: 12387363 [TBL] [Abstract][Full Text] [Related]
3. Iron and alpha-synuclein in the substantia nigra of MPTP-treated mice: effect of neuroprotective drugs R-apomorphine and green tea polyphenol (-)-epigallocatechin-3-gallate. Mandel S; Maor G; Youdim MB J Mol Neurosci; 2004; 24(3):401-16. PubMed ID: 15655262 [TBL] [Abstract][Full Text] [Related]
4. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo. Saporito MS; Brown EM; Miller MS; Carswell S J Pharmacol Exp Ther; 1999 Feb; 288(2):421-7. PubMed ID: 9918541 [TBL] [Abstract][Full Text] [Related]
5. Epigallocatechin Gallate Has a Neurorescue Effect in a Mouse Model of Parkinson Disease. Xu Q; Langley M; Kanthasamy AG; Reddy MB J Nutr; 2017 Oct; 147(10):1926-1931. PubMed ID: 28835392 [No Abstract] [Full Text] [Related]
6. Epigallocatechin gallate protects dopaminergic neurons against 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity by inhibiting microglial cell activation. Li R; Peng N; Du F; Li XP; Le WD Nan Fang Yi Ke Da Xue Xue Bao; 2006 Apr; 26(4):376-80. PubMed ID: 16624731 [TBL] [Abstract][Full Text] [Related]
7. Reduction of dopaminergic degeneration and oxidative stress by inhibition of angiotensin converting enzyme in a MPTP model of parkinsonism. Muñoz A; Rey P; Guerra MJ; Mendez-Alvarez E; Soto-Otero R; Labandeira-Garcia JL Neuropharmacology; 2006 Jul; 51(1):112-20. PubMed ID: 16678218 [TBL] [Abstract][Full Text] [Related]
8. Melatonin protects against oxidative stress caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the mouse nigrostriatum. Thomas B; Mohanakumar KP J Pineal Res; 2004 Jan; 36(1):25-32. PubMed ID: 14675127 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological inactivation of the vesicular monoamine transporter can enhance 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of midbrain dopaminergic neurons, but not locus coeruleus noradrenergic neurons. German DC; Liang CL; Manaye KF; Lane K; Sonsalla PK Neuroscience; 2000; 101(4):1063-9. PubMed ID: 11113355 [TBL] [Abstract][Full Text] [Related]
10. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease. Novikova L; Garris BL; Garris DR; Lau YS Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572 [TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effect of kaempferol against a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease. Li S; Pu XP Biol Pharm Bull; 2011; 34(8):1291-6. PubMed ID: 21804220 [TBL] [Abstract][Full Text] [Related]
15. Effects of green tea polyphenols on dopamine uptake and on MPP+ -induced dopamine neuron injury. Pan T; Fei J; Zhou X; Jankovic J; Le W Life Sci; 2003 Jan; 72(9):1073-83. PubMed ID: 12495785 [TBL] [Abstract][Full Text] [Related]
16. Roles of catalase and hydrogen peroxide in green tea polyphenol-induced chemopreventive effects. Yamamoto T; Lewis J; Wataha J; Dickinson D; Singh B; Bollag WB; Ueta E; Osaki T; Athar M; Schuster G; Hsu S J Pharmacol Exp Ther; 2004 Jan; 308(1):317-23. PubMed ID: 14569057 [TBL] [Abstract][Full Text] [Related]
17. Neuroprotection by sodium salicylate against 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-induced neurotoxicity. Mohanakumar KP; Muralikrishnan D; Thomas B Brain Res; 2000 May; 864(2):281-90. PubMed ID: 10802035 [TBL] [Abstract][Full Text] [Related]
18. The PPARgamma agonist pioglitazone is effective in the MPTP mouse model of Parkinson's disease through inhibition of monoamine oxidase B. Quinn LP; Crook B; Hows ME; Vidgeon-Hart M; Chapman H; Upton N; Medhurst AD; Virley DJ Br J Pharmacol; 2008 May; 154(1):226-33. PubMed ID: 18332857 [TBL] [Abstract][Full Text] [Related]
19. Elevation of neuronal MAO-B activity in a transgenic mouse model does not increase sensitivity to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Andersen JK; Frim DM; Isacson O; Beal MF; Breakefield XO Brain Res; 1994 Sep; 656(1):108-14. PubMed ID: 7804823 [TBL] [Abstract][Full Text] [Related]
20. Theaflavin, a black tea polyphenol, protects nigral dopaminergic neurons against chronic MPTP/probenecid induced Parkinson's disease. Anandhan A; Tamilselvam K; Radhiga T; Rao S; Essa MM; Manivasagam T Brain Res; 2012 Jan; 1433():104-13. PubMed ID: 22138428 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]